InsidersTradesSigma
Track the Scinai Immunotherapeutics Ltd. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €1.5m. The latest transaction was filed on 18 June 2026 (Attribution). Among the most active insiders: GERMAIN MARK. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Scinai Immunotherapeutics Ltd. es una empresa centrada en el desarrollo de tratamientos inmunoterapéuticos. Cotiza en NASDAQ.